SwePub
Sök i SwePub databas

  Extended search

Träfflista för sökning "WFRF:(Gregson Simon) "

Search: WFRF:(Gregson Simon)

  • Result 1-4 of 4
Sort/group result
   
EnumerationReferenceCoverFind
1.
  • Byass, Peter, et al. (author)
  • InterVA-4 as a public health tool for measuring HIV/AIDS mortality : a validation study from five African countries
  • 2013
  • In: Global Health Action. - : Informa UK Limited. - 1654-9716 .- 1654-9880. ; 6:1
  • Journal article (peer-reviewed)abstract
    • BACKGROUND: Reliable population-based data on HIV infection and AIDS mortality in sub-Saharan Africa are scanty, even though that is the region where most of the world's AIDS deaths occur. There is therefore a great need for reliable and valid public health tools for assessing AIDS mortality.OBJECTIVE: The aim of this article is to validate the InterVA-4 verbal autopsy (VA) interpretative model within African populations where HIV sero-status is recorded on a prospective basis, and examine the distribution of cause-specific mortality among HIV-positive and HIV-negative people.DESIGN: Data from six sites of the Alpha Network, including HIV sero-status and VA interviews, were pooled. VA data according to the 2012 WHO format were extracted, and processed using the InterVA-4 model into likely causes of death. The model was blinded to the sero-status data. Cases with known pre-mortem HIV infection status were used to determine the specificity with which InterVA-4 could attribute HIV/AIDS as a cause of death. Cause-specific mortality fractions by HIV infection status were calculated, and a person-time model was built to analyse adjusted cause-specific mortality rate ratios.RESULTS: The InterVA-4 model identified HIV/AIDS-related deaths with a specificity of 90.1% (95% CI 88.7-91.4%). Overall sensitivity could not be calculated, because HIV-positive people die from a range of causes. In a person-time model including 1,739 deaths in 1,161,688 HIV-negative person-years observed and 2,890 deaths in 75,110 HIV-positive person-years observed, the mortality ratio HIV-positive:negative was 29.0 (95% CI 27.1-31.0), after adjustment for age, sex, and study site. Cause-specific HIV-positive:negative mortality ratios for acute respiratory infections, HIV/AIDS-related deaths, meningitis, tuberculosis, and malnutrition were higher than the all-cause ratio; all causes had HIV-positive:negative mortality ratios significantly higher than unity.CONCLUSIONS: These results were generally consistent with relatively small post-mortem and hospital-based diagnosis studies in the literature. The high specificity in cause of death attribution achieved in relation to HIV status, and large differences between specific causes by HIV status, show that InterVA-4 is an effective and valid tool for assessing HIV-related mortality.
  •  
2.
  • Lodeiro, Pablo, et al. (author)
  • Solid–Liquid Equilibria in Aqueous Solutions of Tris, Tris-NaCl, Tris-TrisHCl, and Tris-(TrisH)2SO4 at Temperatures from 5 to 45 °C
  • 2021
  • In: Journal of Chemical and Engineering Data. - : American Chemical Society (ACS). - 0021-9568 .- 1520-5134. ; 66:1, s. 437-455
  • Journal article (peer-reviewed)abstract
    • The substance Tris (or THAM, 2-amino-2-hydroxymethyl-1,3-propanediol) is used in the preparation of pH buffer solutions for applications in natural water chemistry, including seawater. The development of a chemical speciation model of buffer solutions containing Tris, TrisH+, and the major ions of seawater is desirable, so that the effects of changes in the composition and concentration of the medium on pH can be calculated. The Pitzer activity coefficient equations, commonly used in such speciation models, describe the thermodynamic properties of solutions in terms of interactions between dissolved ions and uncharged solute species. To determine some of these interactions, we have measured solubilities of Tris(s) in water and aqueous solutions of NaCl, TrisHCl, and (TrisH)2SO4 and the solubility of NaCl(s) in aqueous Tris(aq), from 5 to 45 °C. We report measurements of the water activities of Tris solutions at 293.5 K to high supersaturation with respect to the solid. Using the Pitzer equations, we compare our results to literature data yielding stoichiometric dissociation constants of TrisH+ in aqueous NaCl, and to electromotive forces of cells containing dissolved Tris, TrisHCl, and NaCl. Values of parameters for the interactions of Tris with the ions TrisH+, Na+, and SO42– at 25 °C are determined.
  •  
3.
  • Morris, John A, et al. (author)
  • An atlas of genetic influences on osteoporosis in humans and mice.
  • 2019
  • In: Nature genetics. - : Springer Science and Business Media LLC. - 1546-1718 .- 1061-4036. ; 51, s. 258-266
  • Journal article (peer-reviewed)abstract
    • Osteoporosis is a common aging-related disease diagnosed primarily using bone mineral density (BMD). We assessed genetic determinants of BMD as estimated by heel quantitative ultrasound in 426,824 individuals, identifying 518 genome-wide significant loci (301 novel), explaining 20% of its variance. We identified 13 bone fracture loci, all associated with estimated BMD (eBMD), in ~1.2 million individuals. We then identified target genes enriched for genes known to influence bone density and strength (maximum odds ratio (OR)=58, P=1 × 10-75) from cell-specific features, including chromatin conformation and accessible chromatin sites. We next performed rapid-throughput skeletal phenotyping of 126 knockout mice with disruptions in predicted target genes and found an increased abnormal skeletal phenotype frequency compared to 526 unselected lines (P<0.0001). In-depth analysis of one gene, DAAM2, showed a disproportionate decrease in bone strength relative to mineralization. This genetic atlas provides evidence linking associated SNPs to causal genes, offers new insight into osteoporosis pathophysiology, and highlights opportunities for drug development.
  •  
4.
  •  
Skapa referenser, mejla, bekava och länka
  • Result 1-4 of 4

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view